Yueyue Li: Clinical Trials

2 completed, 2 recruiting, 1 not yet recruiting. 1 Not applicable.

By phase and status

Phase	Trials	Status
Not applicable	1	Not yet recruiting 1

Follow Yueyue Li: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
7-day High-Dose Vonoprazan-amoxicillin Dual Therapy Versus 14-day Vonoprazan-amoxicillin Dual Therapy for H. Pylori 7-day high-dose vonoprazan-amoxicillin dual therapy group, 14-day vonoprazan-amoxicillin dual therapy group - Helicobacter	Not applicable	Not yet recruiting	Yueyue Li	290	2026-02-01	2026-01-20
Registry for the Management of Helicobacter Pylori Infection in Shandong Province Doctors prescribe Helicobacter pylori treatment regimens for patients based on current guidelines and consensus statements, tailored to individual circumstance, not involve any intervention procedure. - HELICOBACTER PYLORI INFECTIONS		Recruiting	Yueyue Li	10000	2026-02-01	2026-04-02
P-CABs-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication Doctors prescribe Helicobacter pylori treatment regimens for patients based on current guidelines and consensus statements, tailored to individual circumstances，not involve any intervention procedures - Helicobacter Pylori Infection		Recruiting	Yueyue Li	1730	2025-12-16	2025-12-23
Efficacy and Safety of 7-day Triple Therapy Containing Amoxicillin and Tetracycline Versus 14-day Dual Therapy for Helicobacter Pylori Eradication 7-day triple therapy, 14-day dual therapy - HELICOBACTER PYLORI INFECTIONS		Completed	Yueyue Li	508	2025-11-01	2026-01-12
Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication This study is a retrospective study, and all data have been collected in advance with no active intervention required. - Helicobacter Pylori Infection		Completed	Yueyue Li	1730	2022-01-01	2025-09-11

Countries

China (5)